Vivani Medical VANI
NASDAQ VANI
$1.13 +0.01 (+0.89%)
As of: Oct 21, 2026 · 11:24 AM EDT

Vivani Medical (VANI) Short term Debt (2020 - 2021)

Updated

Vivani Medical (VANI) recorded Short term Debt of $2.2 million in Q1 2021, unchanged from the prior quarter.

Analysis

Vivani Medical (VANI) Short term Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Vivani Medical 98.41 Mn 39.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 2.20 Mn
Dec 31, 2020 2.20 Mn
API Access

Vivani Medical Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VANI&period=max&api_key=YOUR_API_KEY